CENTESSA PHARMACEUTICALS-ADR
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About CNTA
Centessa Pharmaceuticals plc is a United Kingdom-based clinical-stage pharmaceutical company. Its advanced programs include a hemophilia program, an orexin agonist program for the treatment of narcolepsy and other sleep-wake disorders, and an immuno-oncology program focused on its LockBody technology platform. SerpinPC, its advanced product candidate, is an investigational, potentially first-in-class subcutaneously administered novel inhibitor of activated protein C for hemophilia. Its Orexin Receptor 2 (OX2R) Agonist Program includes ORX750, which is an investigational, orally administered, selective OX2R agonist designed to directly target the underlying pathophysiology of orexin neuron loss in narcolepsy type 1 and to address sleep-wake disorders with normal orexin levels such as narcolepsy type 2 and idiopathic hypersomnia. It is also exploring follow-up orexin agonists for potential expansion opportunities into a range of sleep-wake disorders and broader neurological indications.
Find out what a historical investment in CENTESSA PHARMACEUTICALS-ADR would be worth today using our CNTA stock calculator.
$1.66B
-
0.00%
942.02K
$13.07
$12.39
$12.40
$19.09
$8.46
Ready to start your investing journey with Stake?
Open an accountCNTA FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CNTA
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CNTA
on Stake
Buy CNTA from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of CNTA from only US$10 with fractional shares
